Total Payments
$487.51
2020 Payments
$35.39
Companies
15
Transactions
24
Medicare Patients
7,116
Medicare Billing
$474,801
Payment Breakdown by Category
Food & Beverage$462.76 (94.9%)
Research$24.75 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $462.76 | 23 | 94.9% |
| Unspecified | $24.75 | 1 | 5.1% |
Payments by Type
General
$462.76
23 transactions
Research
$24.75
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $86.67 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $71.00 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $64.74 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.11 | 2 | $0 (2018) |
| Rigel Pharmaceuticals, Inc. | $25.64 | 1 | $0 (2019) |
| AbbVie, Inc. | $24.75 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $19.67 | 1 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $18.77 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $18.31 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $18.20 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $35.39 | 2 | Janssen Biotech, Inc. ($18.41) |
| 2019 | $196.94 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($57.41) |
| 2018 | $120.71 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($61.11) |
| 2017 | $134.47 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($29.26) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/05/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Oncology | ||||||
| 01/09/2020 | Celgene Corporation | Revlimid (Drug), Pomalyst | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Hematology | ||||||
| 12/11/2019 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 10/01/2019 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: HEMATOLOGY | ||||||
| 09/27/2019 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Oncology | ||||||
| 08/22/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Hematology/Oncology | ||||||
| 06/10/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Oncology | ||||||
| 05/29/2019 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Hematology | ||||||
| 03/13/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Oncology | ||||||
| 01/10/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Oncology | ||||||
| 11/14/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $27.03 | General |
| 09/24/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: HEMATOLOGY | ||||||
| 08/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 03/14/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $34.08 | General |
| 10/11/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 10/05/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 09/20/2017 | AbbVie, Inc. | — | — | In-kind items and services | $24.75 | Research |
| 05/24/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 04/05/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Oncology | ||||||
| 02/22/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: Oncology | ||||||
| 01/12/2017 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,397 | 4,201 | $654,325 | $154,773 |
| 2022 | 19 | 1,476 | 2,693 | $423,830 | $97,591 |
| 2021 | 18 | 1,622 | 3,020 | $490,140 | $110,956 |
| 2020 | 17 | 1,621 | 2,963 | $467,382 | $111,481 |
Total Patients
7,116
Total Services
12,877
Medicare Billing
$474,801
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 663 | 1,411 | $268,090 | $47,540 | 17.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 167 | 265 | $64,925 | $20,139 | 31.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 185 | 738 | $62,730 | $19,225 | 30.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 312 | 395 | $51,350 | $12,667 | 24.7% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 123 | 196 | $40,768 | $12,661 | 31.1% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 58 | 62 | $26,908 | $8,327 | 30.9% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 144 | 231 | $34,650 | $8,094 | 23.4% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 46 | 46 | $22,485 | $7,217 | 32.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 55 | 119 | $17,850 | $4,566 | 25.6% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 42 | 58 | $10,730 | $3,339 | 31.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 102 | 113 | $18,306 | $2,808 | 15.3% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 43 | 48 | $5,088 | $1,580 | 31.0% |
| 84165 | Protein measurement, serum | Facility | 2023 | 73 | 91 | $4,867 | $1,483 | 30.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 27 | 47 | $3,720 | $1,144 | 30.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 75 | 77 | $6,391 | $788.12 | 12.3% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 55 | 59 | $2,419 | $658.94 | 27.2% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 119 | 130 | $4,290 | $513.48 | 12.0% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 12 | 12 | $2,100 | $475.56 | 22.6% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 24 | 24 | $1,440 | $429.84 | 29.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 31 | 37 | $2,183 | $405.81 | 18.6% |
| 88332 | Pathology examination of specimen during surgery, each additional tissue block | Facility | 2023 | 13 | 13 | $1,404 | $369.85 | 26.3% |
| 84166 | Protein measurement, body fluid | Facility | 2023 | 15 | 16 | $760.27 | $260.79 | 34.3% |
| 88302 | Pathology examination of tissue using a microscope | Facility | 2023 | 13 | 13 | $871.00 | $80.60 | 9.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 496 | 1,081 | $205,390 | $37,021 | 18.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 102 | 174 | $42,956 | $13,400 | 31.2% |
About Dr. Brenda Ng, M.D
Dr. Brenda Ng, M.D is a Anatomic Pathology healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316021678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brenda Ng, M.D has received a total of $487.51 in payments from pharmaceutical and medical device companies, with $35.39 received in 2020. These payments were reported across 24 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($462.76).
As a Medicare-enrolled provider, Ng has provided services to 7,116 Medicare beneficiaries, totaling 12,877 services with total Medicare billing of $474,801. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Location Mountain View, CA
- Active Since 10/24/2006
- Last Updated 11/07/2016
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1316021678
Products in Payments
- DARZALEX (Biological) $71.00
- Xofigo (Drug) $37.22
- Nubeqa (Drug) $35.19
- Tavalisse (Drug) $25.64
- JADENU (Drug) $24.98
- PROMACTA (Drug) $24.84
- TAGRISSO (Drug) $19.67
- Imbruvica (Drug) $18.77
- XARELTO (Drug) $18.20
- Revlimid (Drug) $16.98
- Kyprolis (Biological) $16.42
- Halaven (Drug) $16.28
- TASIGNA (Drug) $14.92
- OPDIVO (Biological) $14.78
- Stivarga (Drug) $14.26
- JAKAFI (Drug) $14.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Mountain View
Jason Hipp, Md, MD
Anatomic Pathology — Payments: $4,718
Anatomic Pathology $4,718
Dr. Joshua Sickel, M.d, M.D
Anatomic Pathology — Payments: $124.99
Anatomic Pathology $124.99
Dr. John Collin, M.d, M.D
Anatomic Pathology — Payments: $19.18
Anatomic Pathology $19.18
Dr. Michael Barnes, Md, MD
Anatomic Pathology
Anatomic Pathology